Magazines : Investors Business Daily

Binding: Magazine
First Issue Lead Time: 2-4 weeks
Format: Newspaper Subscription
Issues Per Year: 252
Label: Finadco
Magazine Type: Trade magazine
Manufacturer: Finadco
Number Of Issues: 252
Publisher: Finadco
Studio: Finadco
Subscription Length: 365 days
Sales Rank: 2196

Related Items:

Editorial Review:

Product Description:
Newspaper covering companies, industries, potentially successful stocks, and developments in the economy, as well as providing analysis of national news stories.

Customer Reviews

Average Rating: out of 5 stars

Rating:

- IBD does a good job
When looking for info on the world of stocks and bonds the IBD is a good place to start.

Rating:

- Good Stock Newspaper but very reactionary
This is a good newspaper with TONS of financial data on individual stocks. But their recommendations are typically very reactionary and are pure momentum picks(where the stock has already appreciated substantially). Rarely are there any sort of contrarian picks or stock that have not already moved a good percentage in price.

Also, as has been mentioned before, their editorials are so right-wing that it makes for nothing more than sensational comedy.

Rating:

- Great paper for Investing
This is a great paper for investors who like to do research. It is not a paper for editorial content. I found IBD's investment approach very logical. They give you all the data you need to find quality stocks. I have never read the editorials because their reputation. If I want editorial content I will go to newspapers or magazines.

Rating:

- Worth the Price/Ignore the Editorials if You Like
The advice given in IBD is tremendously useful to both the novice investor and to the more seasoned investor. Following the CAN SLIM rules set forth by IBD along with the rules for investment success that IBD provides will enable you to be successful in your investment endeavors. The IBD 100 is a useful tool in which IBD ranks the top 100 stocks, based on fundamentals, etc. Obviously, the editorials prove to be controversial. If you're interested in making money and you don't agree with the views ... Read More

Rating:

- Useful Investment Info, But Misguided Editorializing
IBD is a useful investment tool, and Bill O'Neil's investment approach is one that a person can employ profitably.

Sadly, and as other reviewers have rightly noted, IBD's editorializing is both extreme and often seems to lack a careful analysis of the facts on any given issue (the facts being our one path to the truth).

Please, Bill O'Neil, when even conservative George Will can rightly criticize George W. Bush's foreign policy, when eminent scientists around the world state ... Read More

Browse for similar items by category: